Hematopoiesis is not clonal in healthy elderly women.
paper
Cited
Public
Unavailable
- Authors
- Swierczek, Sabina I; Agarwal, Neeraj; Nussenzveig, Roberto H; Rothstein, Gerald; Wilson, Andrew; Artz, Andrew; Prchal, Josef T
- Year
- 2008
- Journal
- Blood
- PMID
- 18641369
- DOI
- 10.1182/blood-2008-03-143925
- PMCID
- PMC2569172
Clonality assays, based on X-chromosome inactivation, discriminate active from inactive alleles. Skewing of X-chromosome allelic usage, based on preferential methylation of one of the HUMARA alleles, was reported as evidence of clonal hematopoiesis in approximately 30% of elderly women. Using a quantitative, transcriptionally based clonality assay, we reported X-chromosome-transcribed allelic ratio in blood cells of healthy women consistent with random X-inactivation of 8 embryonic hematopoietic stem cells. Furthermore, we did not detect clonal hematopoiesis in more than 200 healthy nonelderly women. In view of the susceptibility of aging hematopoietic stem cells to epigenetic dysregulation, we reinvestigated the issue of clonality in elderly women. Forty healthy women (ages 65-92 years; mean, 81.3 years) were tested by a novel, quantitative polymerase chain reaction (qPCR) transcriptional clonality assay. We did not detect clonal hematopoiesis in any of the tested subjects. We also tested DNA from the same granulocyte samples using the methylation-based HUMARA assay, and confirmed previous reports of approximately 30% extensively skewed or monoallelic methylation, in agreement with likely age-related deregulated methylation of the HUMARA gene locus. We conclude that the transcriptionally based X-chromosome clonality assays are suitable for evaluation of clonal hematopoiesis in elderly women.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | 2012 | 22561516 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| TRiXi: A Multi-Target Tandem Repeat-Based Method for Accurate Detection of X-Inactivation Skewing in Humans | Goldmann D et al. | β | 2025 | β |
| Effects of Systemic Peroxisome Proliferator-Activated Receptor Gamma Inhibition on Bone and Immune Cells in Aged Female Mice. | Shi X et al. | β | 2024 | β |
| Novel germline JAK2<sup>R715T</sup> mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon. | Song J et al. | β | 2024 | β |
| Screening of early-staged colorectal neoplasia by clonal hematopoiesis-based liquid biopsy and machine-learning. | Hsu YC et al. | β | 2022 | β |
| 60 Years of clonal hematopoiesis research: From X-chromosome inactivation studies to the identification of driver mutations. | Ayachi S et al. | β | 2020 | β |
| Directional X Chromosome Skewing of White Blood Cells from Subjects with Heterozygous Mosaicism for the Variant IRAK1 Haplotype. | Morcillo P et al. | β | 2020 | β |
| Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis. | Halbritter F et al. | β | 2019 | β |
| JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera. | Patel AB et al. | β | 2019 | β |
| ICUS/CCUS/CHIP: basics & beyond. | Jain M et al. | β | 2017 | β |
| Skewed X-chromosome inactivation and XIST locus methylation levels do not contribute to the lower prevalence of Parkinson's disease in females. | Sharma A et al. | β | 2017 | β |
| Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women. | Wiedmeier JE et al. | β | 2016 | β |
| Have humans lost control: The elusive X-controlling element. | Peeters SB et al. | β | 2016 | β |
| Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer. | Adams PD et al. | β | 2015 | β |
| Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms. | Swierczek S et al. | β | 2015 | β |
| Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? | Grove CS et al. | β | 2014 | β |
| Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing. | Szelinger S et al. | β | 2014 | β |
| The evolution of cellular deficiency in GATA2 mutation. | Dickinson RE et al. | β | 2014 | β |
| The relationship of JAK2(V617F) and acquired UPD at chromosome 9p in polycythemia vera. | Wang L et al. | β | 2014 | β |
| Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes. | Wang L et al. | β | 2014 | β |
| Canine cutaneous histiocytomas are clonal lesions as defined by X-linked clonality testing. | Delcour NM et al. | β | 2013 | β |
| Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. | Boonyawat B et al. | β | 2013 | β |
| High frequency of the X-chromosome inactivation in young female patients with high-grade glioma. | Li G et al. | β | 2013 | β |
| Human X-chromosome inactivation pattern distributions fit a model of genetically influenced choice better than models of completely random choice. | Renault NK et al. | β | 2013 | β |
| Novel exon 2 Ξ± spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct Ξ± spectrin defects. | Swierczek S et al. | β | 2013 | β |
| Review of therapeutic options and the management of patients with myelodysplastic syndromes. | Γzcan MA et al. | β | 2013 | β |
| Skewed X-chromosome inactivation in patients with esophageal carcinoma. | Li G et al. | β | 2013 | β |
| Skewed X-inactivation patterns in ageing healthy and myelodysplastic haematopoiesis determined by a pyrosequencing based transcriptional clonality assay. | Mossner M et al. | β | 2013 | β |
| X chromosome inactivation pattern in BRCA gene mutation carriers. | Manoukian S et al. | β | 2013 | β |
| Age-dependent skewing of X chromosome inactivation appears delayed in centenarians' offspring. Is there a role for allelic imbalance in healthy aging and longevity? | Gentilini D et al. | β | 2012 | β |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | Laurie CC et al. | β | 2012 | β |
| Methylation of AR locus does not always reflect X chromosome inactivation state. | Swierczek SI et al. | β | 2012 | β |
| Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cells. | Roehl AC et al. | β | 2012 | β |
| A history of the discovery of random x chromosome inactivation in the human female and its significance. | Balderman S et al. | β | 2011 | β |
| Chronic hemolytic anemia is associated with a new glucose-6-phosphate dehydrogenase in-frame deletion in an older woman. | Manco L et al. | β | 2011 | β |
| Convergent mechanisms of somatic mutations in polycythemia vera. | Wang K et al. | β | 2011 | β |
| Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia. | Bluteau D et al. | β | 2011 | β |
| Extent of hematopoietic involvement by TET2 mutations in JAK2VβΆΒΉβ·F polycythemia vera. | Swierczek SI et al. | β | 2011 | β |
| Familial skewed X-chromosome inactivation linked to a component of the cohesin complex, SA2. | Renault NK et al. | β | 2011 | β |
| Polycomb group proteins in hematopoietic stem cell aging and malignancies. | Klauke K et al. | β | 2011 | β |
| Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves. | Nelson KS et al. | β | 2010 | β |
| Novel genetic aspects of Klinefelter's syndrome. | TΓΌttelmann F et al. | β | 2010 | β |
| Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012). | Slovak ML et al. | β | 2010 | β |
| Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis. | Broen JC et al. | β | 2010 | β |
| Does HUMARA assay for assessment of clonal hematopoiesis have shortcomings? | Agarwal N et al. | β | 2009 | β |
| Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies. | Busque L et al. | β | 2009 | β |
| X chromosome inactivation in clinical practice. | Orstavik KH | β | 2009 | β |
| Stem cell aging: survival of the laziest? | Muller-Sieburg C et al. | β | 2008 | β |